Synthesis of BILN 2061, an HCV NS3 protease inhibitor with proven antiviral effect in humans

Organic Letters

Volumn 6, Issue 17, 2004, Pages 2901-2904

  Faucher, Anne Marie ^a   Bailey, Murray D ^a   Beaulieu, Pierre L ^a   Brochu, Christian ^a   Duceppe, Jean Simon ^a   Ferland, Jean Marie ^a   Ghiro, Elise ^a   Gorys, Vida ^a   Halmos, Ted ^a   Kawai, Stephen H ^a   Poirier, Martin ^a   Simoneau, Bruno ^a   Tsantrizos, Youla S ^a   Llinàs Brunet, Montse ^a  

^a BOEHRINGER INGELHEIM CANADA LTD   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BILN 2061; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CHEMICAL PROCEDURES; DRUG SCREENING; DRUG SYNTHESIS; HEPATITIS C VIRUS;

ANTIVIRAL AGENTS; CARBAMATES; HEPACIVIRUS; HUMANS; MACROCYCLIC COMPOUNDS; MOLECULAR STRUCTURE; PROTEASE INHIBITORS; QUINOLINES; THIAZOLES; VIRAL NONSTRUCTURAL PROTEINS;

EID: 4444345444     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol0489907     Document Type: Article

References (43)

1. (a) Choo, Q.-L.; Kuo, G.; Weiner, A. J.; Overby, L. R.; Bradley, D. W.; Houghton, M. Science 1989, 244, 359.
2. (b) The Hepatits C Viruses; Hagedorn, C. H., Rice, C. M., Eds.; Springer: Berlin, 2000; Curr. Top. Microbiol. Immunol. 242.
3. (b) The Hepatits C Viruses; Hagedorn, C. H., Rice, C. M., Eds.; Springer: Berlin, 2000; Curr. Top. Microbiol. Immunol. 242.
4. Cornberg, M.; Wedemeyer, H.; Manns, M. P. Curr. Gastroenterol. Rep. 2002, 4, 23.
5. Reed, K. E.; Rice, C. M. Curr. Top. Microbiol. Immunol. 2000, 242, 55.
6. Beaulieu, P. L.; Llinàs-Brunet, M. Curr. Med. Chem.: Anti-Infect. Agents 2002, 1, 163.
7. Kolykalov, A.; Mihalik, K.; Feinstone, S. M.; Rice, C. M. J. Virol. 2000, 74, 2046.
8. (a) Llinàs-Brunet, M.; Bailey, M.; Fazal, G.; Goulet, S.; Halmos, T.; LaPlante, S.; Maurice, R.; Poirier, M.; Poupart, M.-A.; Thibeault, D.; Wernic, D.; Lamarre, D. Bioorg. Med. Chem. Lett. 1998, 8, 1713.
9. (b) Steinküler, C.; Biasol, G.; Brunette, M.; Urbani, A.; Koch, U.; Cortese, R.; Pessi, A.; De Francesco, R. Biochemistry 1998, 37, 8899.
10. (a) Llinàs-Brunet, M.; Bailey, M.; Bolger, G.; Brochu, C.; Faucher, A.-M.; Ferland, J.-M.; Garneau, M.; Ghiro, E.; Gorys, V.; Grand-Maître, C.; Halmos, T.; Lapeyre-Paquette, N.; Liard, F.; Poirier, M.; Rhéaume, M.; Tsantrisos, Y.; Lamarre, D. J. Med. Chem. 2004, 47, 1605.
11. (b) Rancourt, J.; Cameron, D.; Gorys, V.; Lamarre, D.; Poirier, M.; Llinàs-Brunet, M. J. Med. Chem. 2004, 47, 2511.
12. (c) Goudreau, N.; Cameron, D. R.; Bonneau, P.; Gorys, V.; Plouffe, C.; Poirier, M.; Lamarre, D.; Llinàs-Brunet, M. J. Med. Chem. 2004, 47, 123.
13. (d) Bailey, M. D.; Halmos, T.; Goudreua, N.; Lescop, E.; Llinàs-Brunet, M. J. Med. Chem. 2004, ASAP.
14. (e) Tsantrizos, Y. S.; Bolger, G.; Bonneau, P.; Cameron, D. R.; Goudreau, N.; Kukolj, G.; LaPlante. S. R.; Llinàs-Brunet, M.; Nar, H.; Lamarre, D. Angew. Chem., Int. Ed. 2003, 42, 1355.
15. (f) Poupart, M. A.; Cameron, D. R.; Chabot, C.; Ghiro, E.; Goudreau, N.; Goulet, S.; Poirier, M.; Tsantrizos, Y. S. J. Org. Chem. 2001, 66, 4743.
16. (g) Llinàs-Brunet, M.; Bailey, M.; Fazal, G.; Ghiro, E.; Gorys, V.; Goulet, S.; Halmos, T.; Maurice, R.; Poirier, M.; Poupart, M.-A.; Rancourt, J.; Thibeault, D.; Wernic, D.; Lamarre, D. Bioorg. Med. Chem. Lett. 2000, 10, 2267.
17. (h) LaPlante, S. R.; Aubry, N.; Bonneau, P. R.; Kukolj, G.; Lamarre, D.; Lefebvre, S.; Li, H.; Llinàs-Brunet, M.; Plouffe, C.; Cameron, D. R. Bioorg. Med. Chem. Lett. 2000, 10, 2271.
18. (a) Reiser, M.; Hinrichsen, H.; Benhamou, Y.; Sentjens, R.; Wedemeyer, H.; Calleja, L.; Forns, X.; Croenlein, J.; Yong, C.; Nehmiz, G.; Steinmann, G. Hepatology 2003, 38 (Suppl. 1), 221 A.
19. (b) Lamarre, D.; Anderson, P. C.; Bailey, M.; Beaulieu, P.; Bolger, G.; Bonneau, P.; Boes, M.; Cameron, D. R.; Cartier, M.; Cordingley, M. G.; Faucher, A.-M.; Goudreau, N.; Kawai, S. H.; Kukolj, G.; Lagace, L.; LaPlante, S. R.; Narjes, H.; Poupart, M.-A.; Rancourt, J.; Sentjens, R. E.; St. George, R.; Simoneau, B.; Steinmann, G.; Thibeault, D.; Tsantrizos, Y. S.; Weldon, S. M.; Yong, C.-L.; Llinàs-Brunet, M. Nature 2003, 426, 186.
20. (c) Benhamou, Y.; Hinrichsen, H.; Sentjens, R.; Reiser, M.; Manns, M. P.; Forns, X.; Avendano, C.; Crönlein, J.; Nehmiz, G.; Steinmann, G. Hepatology 2002, 36, 304A, Abst. 563.
21. (d) Hinrichsen, H.; Benhamou, Y.; Reiser, M.; Sentjens, R.; Wedemeyer, H.; Calleja, J. L.; Forns, X.; Crönlein, J.; Nehmiz, G.; Steinmann, G.; Hepatology 2002, 36, 297A, Abst. 866.
22. Protease subsite nomenclature: Schechter, I.; Berger, A. Biochem. Biophys. Res. Commun. 1967, 27, 157.
23. For reviews on olefin metathesis, see: (a) Schrock, R. R.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2003, 42, 4592. (b) Trnka, T. M.; Grubbs, R. H.; Acc. Chem. Res. 2001, 34, 18. (c) Fürstner, A. Angew. Chem., Int. Ed. 2000, 39, 3012.
24. For reviews on olefin metathesis, see: (a) Schrock, R. R.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2003, 42, 4592. (b) Trnka, T. M.; Grubbs, R. H.; Acc. Chem. Res. 2001, 34, 18. (c) Fürstner, A. Angew. Chem., Int. Ed. 2000, 39, 3012.
25. For reviews on olefin metathesis, see: (a) Schrock, R. R.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2003, 42, 4592. (b) Trnka, T. M.; Grubbs, R. H.; Acc. Chem. Res. 2001, 34, 18. (c) Fürstner, A. Angew. Chem., Int. Ed. 2000, 39, 3012.
26. The synthesis of P1 is briefly described in: Llinàs-Brunet, M.; Bailey, M. D.; Cameron, D.; Ghiro, E.; Goudreau, N.; Poupart, M.-A.; Rancourt, J.; Tsantrizos, Y. S.; Faucher, A.-M.; Halmos, T.; Wernic, D. M.; Simoneau, B.; Boehringer Ingelheim (Canada) Ltd., U.S. patent 6,323,180 B1, 2000; Chem. Abstr. 132:180871. A more detailed account of the synthesis of P1 will be reported separately.
27. Knorr, R.; Trzeciak, A.; Bannwarth, W.; Gillessen, D. Tetrahedron Lett. 1989, 30, 1927.
28. Mitsunobu, O. Synthesis 1981, 1.
29. Burk, M. J.; Allen, J. G.; Kiesman, W. F. J. Am. Chem. Soc. 1998, 120, 657 and references therein.
30. For a discussion on the Perkin related reactions, see: Johnson, J. R. The Perkin Reaction and Related Reactions. In Organic Reactions; Adams, R., Bachmann, E. W., Fieser, L. F., Johnson, J. R., Snyder, H. R., Eds.; John Wiley & Sons: New York, 1942; Vol, 1, Chapter 8, pp 210-255 and references therein.
31. Hengartner, U.; Valentine, D. Jr.; Johnson, K. K.; Larscheid, M. E.; Pigott, F.; Scheidl, F.; Scott, J. W.; Sun, R. C.; Townsend, J. M.; Williams, T. H. J. Org. Chem. 1979, 44, 3741.
32. Byproduct 10 was likely formed by reaction of an enolate derived from 8 with acetic anhydride. When acetic anhydride was replaced by bulkier anhydrides (e.g., isobutyric anhydride) to try to minimize the side reaction leading to 10, the rate of the Perkin reaction was considerably decreased and the reaction profile was less clean.
33. Pham, T.; Lubell, W. D. J. Org. Chem. 1994, 59, 3676.
34. Burk, M. J.; Allen, J. G. J. Org. Chem. 1997, 62, 7054.
35. (a) Miller, S. J.; Blackwell, H. E.; Grubbs, R. H. J. Am. Chem. Soc. 1996, 118, 9606.
36. (b) Kingsbury, J. S.; Harrity, J. P. A.; Bonitatebus, P. J.; Hoveyda, A. H. J. Am. Chem. Soc. 1999, 121, 791.
37. (c) Huang, J.; Stevens, E. D.; Nolan, S. P.; Petersen, J. L. J. Am. Chem. Soc. 1999, 121, 2674.
38. (d) Scholl, M.; Trnka, T. M.; Morgan, J. P.; Grubbs, R. H. Tetrahedron Lett. 1999, 40, 2247.
39. Poirier, M.; Ferland, J.-M.; Tsantrizos, Y. S. Manuscript in preparation.
40. Alternatively, a fully assembled 4-hydroxy-7-methoxy-2-thiazolylquinoline can be coupled to the macrocyclic substrate as described in: Tsantrisos, Y. S.; Cameron, D,; Faucher, A.-M.; Ghiro, E.; Goudreau, N.; Halmos, T.; Llinàs-Brunet, M. Boehringer Ingelheim (Canada) Ltd. U.S. Patent 6,608,027, 2003; Chem. Abstr. 139:197768.
41. Liu, K.-C.; Lu, W.-C.; Lee, L.-C. Taiwan Yaoxue Zazhi 1979, 31, 80; Chem. Abstr. 94:174832.
42. Liu, K.-C.; Lu, W.-C.; Lee, L.-C. Taiwan Yaoxue Zazhi 1979, 31, 80; Chem. Abstr. 94:174832.
43. N2 reaction of mesylated 4-hydroxyproline by 4-hydroxyquinoline derivatives produces a small amount of elimination byproduct that is difficult to separate from the desired substitution product (data not shown).